Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trialogix is a clinical trial technology company that provides integrated Electronic Data Capture (EDC) and Interactive Response Technology (IRT) solutions. Founded in 2001, the company specializes in streamlining clinical data management and randomization processes for the pharmaceutical and biotechnology industries. Its platform offers tools for trial supply management and real-time data access to improve study efficiency and data integrity. The company's services are designed to support Phase I through Phase IV clinical trials across various therapeutic areas. In 2011, Trialogix was acquired by Clinipace Worldwide to bolster its digital clinical research and CRO service offerings. Following the acquisition, its technology was integrated into the Clinipace (now Caidya) ecosystem to provide end-to-end clinical trial management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trialogix.